Prosetta Biosciences Inc.
SAN FRANCISCO, CA · Founded 2013 · CIK 0001659956 · Biotech · Private
Small molecule therapeutics that modulate multi-protein complex assembly
prosetta.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $31M
- 1 Form D · Dec 2015
- 130 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 18
- 3 granted · 15 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $31,096,778 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2513 | Nouscom | — | — |
| 2514 | Somite AI | — | — |
| 2515 | Alligator Bioscience AB (publ) | — | $10M |
| 2516 | Prosetta Biosciences Inc. | — | $31M |
| 2517 | Metselex, Incorporated | — | — |
| 2518 | Radionetics Oncology | — | $54M |
| 2519 | SIVEC BIOTECHNOLOGIES, INC. | — | $3.3M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Molly CoyeDirector
- Michael FarmerDirector · Executive Officer
- Thomas HigginsDirector
- David KeysDirector
- Vishwanath LingappaDirector · Executive Officer
- Karl ManheimDirector
- "Joseph(""Mike"")" McCuneDirector
- Phil SatowDirector
- CJ SylvesterDirector
- Abel WeinribDirector
Patents
- Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeuticsapplication
- Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeuticsgranted
- 2-Thioxothiazolidine-4-One Derivatives And Their Usesapplication
- Isoquinoline Derivatives, Methods of Synthesis and Uses Thereofapplication
- Quinazoline Compounds and Usesapplication
- Phenothiazinyl Compounds and Usesapplication
- Isoquinoline Derivatives, Methods of Synthesis and Uses Thereofgranted
- Host-targeted Pan-respiratory Antiviral Small Molecule Therapeuticsgranted
- Novel Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeuticsapplication
- Isoquinoline Derivatives, Methods Of Synthesis And Uses Thereofapplication
- Isoquinoline Derivatives, Methods of Synthesis and Uses Thereofapplication
- 2-THIOXOTHIAZOLIDINE-4-ONE Derivatives And Their Usesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.